文献速递神经MR

超快速对比增强T1加权3D-EPI评估肿瘤患者颅内强化病灶的临床可行性:与标准3D MPRAGE序列的比较

Clinical Feasibility of Ultrafast Contrast-Enhanced T1-Weighted 3D-EPI for Evaluating Intracranial Enhancing Lesions in Oncology Patients: Comparison with Standard 3D MPRAGE Sequence.
PubMed 文献 · AJNR Am J Neuroradiol · 2022-01-13

本研究纳入61例肿瘤患者,在同一次检查中行对比增强T1WI的3D-EPI与3D MPRAGE序列,由两名神经放射科医生评估图像质量、病灶显示、诊断信心及对比噪声比。3D-EPI在诊断信心、病灶-脑实质对比噪声比和强化病灶数目上与MPRAGE无显著差异,但图像质量、解剖 delineation 和磁化率伪影较差、运动伪影较少,白质/灰质对比噪声比和病灶视觉显示度较低,扫描时间缩短7倍。作者认为超快速3D-EPI T1WI可能适用于易运动的肿瘤患者。

要点

  • 超快速3D-EPI T1WI与标准3D MPRAGE在诊断信心、病灶-脑实质对比噪声比和强化病灶数目上无显著差异。
  • 3D-EPI图像质量和解剖 delineation 较差、磁化率伪影较多,但运动伪影较少。
  • 3D-EPI白质/灰质对比噪声比和病灶视觉显示度低于MPRAGE,扫描时间缩短7倍。

核心结论

  • 超快速3D-EPI T1WI在评估颅内强化病灶时诊断性能与标准MPRAGE相当,图像质量足够,扫描时间缩短7倍,但受图像质量较差和磁化率伪影较多的限制;作者认为其可能适用于易运动的肿瘤患者。

研究设计与样本

  • 单次检查 session 内自身对照研究,纳入61例肿瘤患者,同时行对比增强T1WI的3D-EPI和3D MPRAGE序列,由两名神经放射科医生评估。

关键影像表现/征象

  • 超快速3D-EPI T1WI的图像质量和解剖 delineation 较MPRAGE差,磁化率伪影较多,但运动伪影较少。
  • 超快速3D-EPI T1WI的白质/灰质对比噪声比和病灶视觉显示度低于MPRAGE(P < .001)。

诊断标准与关键数值

  • 超快速3D-EPI T1WI与MPRAGE在诊断信心、病灶-脑实质对比噪声比和强化病灶数目上无显著差异(P > .05)。
  • 超快速3D-EPI T1WI的白质/灰质对比噪声比和病灶视觉显示度低于MPRAGE(P < .001)。

临床应用与阅片要点

  • 作者认为超快速3D-EPI T1WI可能是易运动肿瘤患者的一个可行选择。
  • 阅片时需注意3D-EPI图像质量和解剖 delineation 较差、磁化率伪影较多,但运动伪影较少。

局限性

  • 超快速3D-EPI T1WI受图像质量较差和频繁磁化率伪影的限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Contrast-enhanced 3D T1WI is a preferred sequence for brain tumor imaging despite the long scan time. This study investigated the clinical feasibility of ultrafast contrast-enhanced T1WI by 3D echo-planar imaging compared with a standard contrast-enhanced 3D MPRAGE sequence for evaluating intracranial enhancing lesions in oncology patients.

MATERIALS AND METHODS: Sixty-one patients in oncology underwent brain MR imaging including both contrast-enhanced T1WI, 3D-EPI and 3D MPRAGE, in a single examination session for evaluating intracranial tumors. Two neuroradiologists evaluated image quality, lesion conspicuity, diagnostic confidence, number and size of the lesions, and contrast-to-noise ratio measurements from the 2 different sequences.

RESULTS: Ultrafast 3D-EPI T1WI did not reveal significant differences in diagnostic confidence, contrast-to-noise ratiolesion/parenchyma, and the number of enhancing lesions compared with MPRAGE (P > .05). However, ultrafast 3D-EPI T1WI revealed inferior image quality, inferior anatomic delineation and greater susceptibility artifacts with fewer motion artifacts than images obtained with MPRAGE. The mean contrast-to-noise ratioWM/GM and visual conspicuity of the lesion on ultrafast 3D-EPI T1WI were lower than those of MPRAGE (P < .001).

CONCLUSIONS: Ultrafast 3D-EPI T1WI showed comparable diagnostic performance with sufficient image quality and a 7-fold reduction in scan time for evaluating intracranial enhancing lesions compared with standard MPRAGE, even though it was limited by an inferior image quality and frequent susceptibility artifacts. Therefore, we believe that ultrafast 3D-EPI T1WI may be a viable option in oncology patients prone to movement during imaging studies.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Ryu KH, Baek HJ, Skare S, et al. Clinical Feasibility of Ultrafast Contrast-Enhanced T1-Weighted 3D-EPI for Evaluating Intracranial Enhancing Lesions in Oncology Patients: Comparison with Standard 3D MPRAGE Sequence. AJNR Am J Neuroradiol. 2022. PMID: 35027347. doi:10.3174/ajnr.A7391

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。